Parameter | Spontaneous HCV clearance n = 83 | Persistent HCV RNA positivity n = 104 | P valuea |
---|---|---|---|
Male gender | 43 (51.8) | 57 (54.8) | 0.768 |
Age at RRT onset, years | 53.3 (7.2–85.9) | 47.3 (8.7 –79.5) | 0.011 |
Diabetic nephropathy | 19 (22.9) | 17 (16.3) | 0.270 |
Chronic glomerulonephritis | 16 (19.3) | 37 (35.6) | 0.015 |
Hypertensive nephropathy | 9 (10.8) | 11 (10.6) | 1.000 |
RRT duration, years | 7.12 (0.19–34.01) | 13.32 (0.65–32.81) | 0.002 |
BMI, kg/m2 | 24.43 (16.23–37.93) | 23.18 (15.22–44.8) | 0.165 |
HBsAg positivity | 7 (8.4) | 5 (4.8) | 0.375 |
ALT, IU/L | 12.9 (3–63) | 22 (2–195) | 0.0001 |
AST, IU/L | 15 (8–50) | 22 (7–152) | 0.00005 |
ALP, IU/L | 86.63 (45–803.75) | 110 (34.5–647.25) | 0.024 |
GGT, IU/L | 19.7 (7–692) | 39 (4–498) | 0.001 |
C-reactive protein, mg/L | 5.4 (0.3–105.5) | 5.4 (0–90.7) | 0.536 |
Albumin, g/dL | 3.9 (2–36) | 3.8 (1.9–38) | 0.513 |
Platelet count, × 109/L | 177 (93–397) | 177 (70–405) | 0.353 |
Total cholesterol (mg/dL) | 156 (98.9–280) | 158 (65–259) | 0.394 |
HDL cholesterol (mg/dL) | 38 (16.5–88) | 40 (13–102) | 0.318 |
LDL cholesterol (mg/dL) | 82.5 (32–186.3) | 84 (17.4–174) | 0.700 |
TG (mg/dL) | 139 (36.3–479) | 139 (32–419) | 0.577 |
Non-HDL-cholesterol (mg/dL) | 120.25 (52–241) | 117 (22.5–225) | 0.306 |
LDL/HDL cholesterol ratio | 0.641 (0.101–1.81) | 0.632 (0.084–2.875) | 0.987 |
HDL/TC ratio | 0.236 (0.111–0.505) | 0.272 (0.094–0.685) | 0.054 |
TG/HDL cholesterol ratio | 3.38 (0.65–25.55) | 3.29 (0.74–27.93) | 0.471 |
TG/HDL-cholesterol ratio ≥ 3.8 | 29 (41.4%) | 38 (40.9%) | 1.000 |
IFNL4 rs368234815 TT/TT | 46 (55.4%) | 33 of 102 (32.4%) | 0.002 |